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Abstract: The epidermis, the outer layer of the skin, is formed by stratified keratinocyte layers. The self-renewal of the epidermis is provided by sustained proliferation and differentiation of the keratinocyte stem cells localized to the basal layer of the epidermis. Receptorinteracting protein kinase 4 (RIPK4) is an important regulator of keratinocyte differentiation, mutations of which are associated with
congenital ectodermal malformations. In an attempt to identify the molecular basis of RIPK4’s function, we applied yeast two-hybrid
screen (Y2H) and found basal layer-specific keratin filament component keratin 14 (KRT14) as a novel RIPK4-interacting partner. During keratinocyte differentiation, layer-specific keratin composition is tightly regulated. Likewise, the basal layer specific KRT14/keratin
5 (KRT5) heterodimers are replaced by keratin 1 (KRT1)/keratin 10 (KRT10) in suprabasal layers. The regulation of keratin turnover
is under the control of signaling associated with posttranslational modifications in which phosphorylation plays a major role. In this
study, we verified the KRT14–RIPK4 interaction, which was identified with Y2H, in mammalian cells and showed that the interaction
was direct by using proteins expressed in bacteria. According to our results, the N-terminal kinase domain of RIPK4 is responsible for
KRT14–RIPK4 interaction; however, the RIPK4 kinase activity is dispensable for the interaction. In accordance with their interaction,
RIPK4 and KRT14 colocalize within the cells, particularly at keratin filaments associated with perinuclear ring-like structures. Moreover, RIPK4 did not show any effect on KRT14/KRT5 heterodimer formation. Our results suggest that RIPK4 may regulate the keratin
turnover required for keratinocyte differentiation through interacting with KRT14.
Key words: Keratins, keratinocyte differentiation, RIPK4, protein–protein interactions

1. Introduction
The epidermis is a stratified epithelium that protects the
organism against environmental insults. The maintenance
of the epidermis is provided by sustained proliferation and
differentiation of the keratinocyte stem cells localized to
the basal layer of the epidermis (Fuchs and Nowak, 2008;
Blanpain and Fuchs, 2009). As keratinocyte stem cells
commit to differentiate, they cease to proliferate and start
to move upward to form suprabasal layers, including spinous, granular, and stratum corneum with different biochemical contents and morphologies (Fuchs and Nowak,
2008). In this differentiation process, transcription factor
p63, which is the well-known master regulator of keratinocyte differentiation, regulates the expression of a plethora
of proteins involved in keratinocyte differentiation and
maintenance, including receptor-interacting protein kinase 4 (RIPK4), interferon regulatory factor 6 (IRF6), inhibitory kappa B kinase α (IKKα), and keratin 14 (KRT14)

(Romano et al., 2007; Marinari et al., 2009; Thomason et
al., 2010; Mitchell et al., 2012).
RIPK4 is one of the major determinants of keratinocyte
differentiation, mutations of which were previously associated with Bartsocas–Papas syndrome (BPS) that is characterized by severe congenital epidermal malformations
(Kalay et al., 2012; Mitchell et al., 2012). In the epidermis
of RIPK4-deficient mice, the disruption of keratinocyte
differentiation leads to hyperplasia of the epidermis and
misexpression of layer-specific keratinocyte markers (Holland et al., 2002; Rountree et al., 2010).
Proteins rely on protein–protein interactions to perform their cellular function (Phizicky and Fields, 1995).
The interaction of RIPK4 with transcription factor IRF6
and desmosomal protein plakophilin-1 (Pkp1) promotes
keratinocyte differentiation through activation of keratinocyte-specific gene expression and regulation of desmosome signaling activity (Kwa et al., 2014; Lee et al.,
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2017). Therefore, in this study, we aimed to identify novel
RIPK4-interacting proteins to clarify the molecular basis
of RIPK4’s function in keratinocyte differentiation. For
this purpose, a human keratinocyte cDNA library was
screened by large-scale yeast two-hybrid (Y2H) assay and
keratin filament protein KRT14 was identified as a RIPK4interacting partner.
Keratins, which are the main building blocks of the
intermediate filaments of keratinocytes, are found in
cells as obligate type I (KRT9–28) and type II (KRT1–8
and KRT71–74) heterodimers. These heterodimers align
in an antiparallel fashion to form soluble tetramers that
assemble into keratinocyte filaments (Fuchs and Weber,
1994; Kim et al., 2015). KRT14, which belongs to the type
I keratin family, forms a heterodimer with type II keratin,
KRT5. During keratinocyte differentiation, while the morphology and biochemical content of cells are changing, the
keratin filaments’ composition is changing, as well. Likewise, KRT5/KRT14 heterodimers, which are expressed in
the proliferative basal layer of the epidermis, are replaced
by KRT1/KRT10 heterodimers in the spinous layer (Fuchs
and Nowak, 2008). Basal layer-specific KRT5/KRT14 keratinocyte filaments are important for cell–cell (desmosomes) and cell–basal lamina (hemidesmosomes) attachments (Fuchs and Weber, 1994). Related to their function,
KRT14 and KRT5 mutations are associated with epidermolysis bullosa simplex, an epidermal disorder characterized by fragility of basal keratinocytes and detachment of
the cells from lamina upon physical trauma (Lane, 1994;
Coulombe et al., 2009).
As both KRT14 and RIPK4 are critical proteins important for keratinocyte differentiation and function, analysis
of their interaction is critical for the understanding of the
molecular basis of keratinocyte differentiation. Therefore,
in this study we initially verified the RIPK4/KRT14 interaction, which we identified with Y2H screening, in mammalian and bacterial cells, and then further analyzed the
interaction in terms of responsible RIPK4 domains and
RIPK4 kinase activity. In order to gain insight into the biological significance of the interaction, we also investigated
the effect of RIPK4 on KRT5/KRT14 heterodimer formation.
2. Materials and methods
2.1. Expression vectors and cloning
For the Y2H screen, the N-terminal kinase domain of
RIPK4 (1–340) was subcloned from pCR3 VSV-N-RIPK4
(Meylan et al., 2002) into Gal4-DNA-BD containing pGBKT7 (Clontech, USA) yeast expression plasmid by using
EcoRI-XhoI and EcoRI-SalI (Invitrogen, USA) restriction
enzymes, respectively. For the construction of the mammalian and bacterial expression vectors, the gateway cloning system technology (Thermo Fischer Scientific, USA)
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was applied. Open reading frames (ORFs) of human fulllength (FL) RIPK4 (NM_020639.2) and kinase-dead RIPK4
(K51R) were amplified from pCR3 VSV-RIPK4 (Meylan et
al., 2002) by PCR with primers suitable for gateway cloning. Amplified RIPK4 and K51R ORFs were cloned into
the p3xFlag CMV/DEST expression vector (Invitrogen,
USA) to provide expression of RIPK4 and K51R in mammalian cells in fusion with the N-terminal Flag tag. Additionally, RIPK4 was cloned into pDEST-27 (Invitrogen,
USA) and pcDNA-DEST53 (Invitrogen, USA) expression
vectors for the expression of RIPK4 in mammalian cells in
fusion with N-terminal GST and GFP tags, respectively.
ORFs belonging to RIPK4 domains—RIPK4 N-Ter (containing kinase domain, aa 1–292), ID (aa 278–438), and
C-Ter (containing ID and ankyrin, aa 278–784)—were
amplified from the p3xFlag-RIPK4 expression vector and
cloned into the p3xFlag CMV/DEST expression vector
(Invitrogen, USA). Moreover, RIPK4 was cloned into the
pDEST17 bacterial expression vector (Invitrogen, USA) to
be expressed in bacteria in fusion with the N-terminal His
tag. ORFs of human KRT14 (NM_000526.5) and KRT5
(NM_000424.4) were amplified by using the cDNA obtained from the human keratinocyte HaCaT cells. KRT14
was cloned into the pDEST-27 mammalian expression
vector (Invitrogen, USA) and pGEX-KG/DEST bacterial
expression vector (Invitrogen, USA) in fusion with the Nterminal GST tag. KRT5 was cloned into p3xFlag CMV/
DEST (Invitrogen, USA) in fusion with the N-terminal
Flag tag. All clones were verified with Sanger sequencing
using a genetic analyzer (Applied Biosystems, USA).
2.2. Yeast two-hybrid screen
As bait, the N-terminal region of RIPK4 was cloned into
the pGBKT7 yeast vector (Clontech, USA) in fusion with
the Gal4 DNA binding domain, and the construct was sent
to the German Cancer Research Center (DKFZ, Genomics and Proteomics Core Facilities – Protein Interaction
Screening W150, Germany) for a large-scale Y2H screen.
The human keratinocyte cDNA library, which was expressed in fusion with the Gal4 activation domain from
vector pACT2.2 (Clontech, USA), was used as prey. Bait
and prey proteins were expressed together in the AH109
yeast strain (Clontech, USA) and positive clones were
identified by activation of HIS3 and MEL1 reporters that
are controlled by GAL promoters. The Y2H screen was
repeated three times with 0.4 mM, 0.2 mM, and 0.1 mM
3-aminotriazole (3AT) containing selective medium to
determine strong and weak interactions. Library inserts
were isolated by PCR and analyzed by DNA sequencing.
2.3. Cell lines, cell culturing, and transfections
HEK293T (human embryonic kidney cells), HaCaT (immortalized human keratinocytes), and HeLa (human
cervix adenocarcinoma cell line) cells were cultured in
Dulbecco’s modified Eagle’s medium supplemented with
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10% heat-inactivated FBS and penicillin/streptomycin
(100 µg/mL of each at 37 °C in a humidified atmosphere of
5% CO2). For a transient transfection of HEK293T, HeLa
cells, and HaCaT cells, a standard calcium phosphate protocol (Jordan et al., 1996), DreamFect Gold Transfection
Reagent (Ozbiosciences, USA), and Lipofectamine 2000
reagent (Thermo Fischer Scientific, USA) were used, respectively.
2.4. Application of CRISPR/Cas9 system for knockout of
RIPK4
The CRISPR/Cas9 system was applied to generate the
mutant HaCaT cell lines lacking RIPK4 expression as described (Ran et al., 2013). RIPK4-specific guide RNA (gRNA), which precedes the Protospacer Adjacent Motif
(PAM), 5’ NGG, was designed using Benchling and CHOPCHOP Web software. The applied g-RNA (5’-TCGACGCGGGCGAGTTCAC-3’) targets the region in exon 1 (between the 50th and 68th nucleotides) that corresponds to
the beginning of the RIPK4 kinase domain (between the
66th and 849th nucleotides) (Supplementary Figure 1A).
RIPK4-specific g-RNA was cloned into the Cas9-expressing plasmid, pSpCas9(BB)-2A-Puro (PX459) V2.0 (Addgene #62988, USA) and transfected into the HaCaT cells
by Lipofectamine 2000 reagent (Thermo Fischer Scientific,
USA). After 3 days of selection with puromycin (1 µg/mL),
clonal cell lines were obtained by expanding the single cells
in a regular maintenance medium. To determine the extent
of CRISPR/Cas9-introduced mutations in the RIPK4 gene,
PCR amplified exon 1 was analyzed by sequencing. RIPK4
expression levels were analyzed in mutant HaCaT clones
with western blot using anti-RIPK4. The clone named as
RIPK4 KO was used in this study, considering the higher
efficiency of RIPK4 depletion (Supplementary Figure 1B).
2.5. Antibodies
The following antibodies were used: anti-KRT14 (Abcam,
UK; Cat. No. ab7800), anti-KRT5 (Abcam, UK; Cat. No.
ab52635), anti-RIPK4 (Santa Cruz Biotechnology, USA;
Cat. No. sc-83320), anti-GST (Santa Cruz Biotechnology,
USA; Cat. No. sc-459), anti-Flag M2 (Sigma-Aldrich, USA;
Cat. No. F3165), secondary antibody HRP-conjugated antimouse (Bio-Rad, USA; Cat. No. 170–5047), antirabbit
(Bio-Rad, USA; Cat. No. 170-5045), secondary antimouseCy3 (Abcam, UK; Cat. No. ab97035), and secondary antirabbit-Alexa Fluor 488 (Abcam, UK; Cat. No. ab150061).
2.6. Cell lysis and western blotting
Cells were washed with ice-cold PBS and then lysed using
TNTE buffer (50 mM Tris-Cl [pH 7.4], 150 mM NaCl, 1
mM EDTA, 1% Triton X-100, 10% glycerol, 5 mM Na4P2O7,
2 mM Na3VO4, 20 mM NaF, 1 mM PMSF, and 1X protease inhibitor cocktail tablet [Roche, Switzerland]) on ice
for 30 min. The lysates were centrifuged at 16,000 × g for
15 min and protein concentrations were measured using a

BCA protein assay kit (Thermo Fischer Scientific, USA).
Beads were boiled in SDS-PAGE loading buffer (0.25 M
Tris-CI [pH 6.8], 10% SDS, 50% glycerol, 0.01% Bromophenol Blue [Merck, Germany]) and then loaded on 7.5%
SDS-PAGE gels. After proteins were transferred to a nitrocellulose membrane (Bio-Rad, USA), the membrane was
blocked with 5% BSA in Tris-buffered saline (TBS) with
0.05% Tween 20. Indicated primary and secondary antibodies were used according to the manufacturer’s instructions. Protein bands were visualized with the ChemiDoc
MP Imaging System (Bio-Rad, USA).
2.7. Coimmunoprecipitation
The cell lysate was incubated with 1 µg of anti-GST and anti-Flag antibody for 2 h at 4 °C to immunoprecipitate (IP)
GST-KRT14 and Flag-KRT5 proteins. Then 20 µL of equilibrated protein G agarose beads (Invitrogen, USA) were
added to the samples and tubes were further incubated for
2 h at 4 °C with constant rotation. For immunoprecipitation of endogenous RIPK4, 1.7 mg of total protein containing cell lysate was incubated with 3 µg of anti-RIPK4 for 2
h at 4 °C. Then 30 µL of equilibrated protein G agarose,
which was previously blocked with 0.1% BSA, was added
to the samples and the samples were further incubated for
2 h at 4 °C with constant rotation. After the beads were
washed five times with a wash buffer (50 mM Tris-Cl [pH
7.4], 150 mM NaCl, 1 mM EDTA [pH 8.0], 0.1% Triton
X-100), the proteins were eluted with SDS-PAGE loading
buffer and analyzed by western blot.
2.8. Bacterial expression of GST/His proteins and pulldown assay
His-RIPK4 and GST-KRT14 were transformed into E. coli
BL21 DE3 and BL21 AI strains, respectively, and grown
at 37 °C until the OD600 of the culture reached 0.6. The
bacterial cells were treated with 0.2% L-arabinose and 100
mM IPTG (isopropyl 1-thio-D-galactopyranoside) for 2 h
and 4 h at 20 °C to induce expression of His-RIPK4 and
GST-KRT14, respectively. GST-, GST-KRT14-, and HisRIPK4-expressing bacterial cells were lysed in ice-cold lysis buffer (10 mM Tris-Cl [pH 7.5], 150 mM NaCl, 0.5 mM
EDTA [pH 7.0], 0.5% Nonidet P-40, 1 mM PMSF). GST
and GST-KRT14 were bound to GST trap beads (Chromotek, Germany) and the samples were incubated with
His-RIPK4 containing bacterial cell lysate for 1 h at 4 °C.
After the beads were washed with a wash buffer (10 mM
Tris-Cl [pH 7.5], 300 mM NaCl, 0.5 mM EDTA, and 0.1%
NP-40) five times at 4 °C, the proteins were eluted from the
beads by using 0.2 M glycine-HCl (pH 2.5) and analyzed
by western blot.
2.9. Fluorescence microscopy
The FLAG-RIPK4- and GST-KRT14-expressing vectors
were transfected into the HeLa and HaCaT cells. At 24 h
after transfection, the cells were fixed with 4% paraformal-
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dehyde in phosphate-buffered saline (PBS) for 10 min and
permeabilized with 0.2% Triton X-100 in PBS for 5 min.
Between each step, cells were washed five times with PBS.
The samples were blocked in 10% goat serum in PBS before addition of primary antibodies, anti-FLAG (1:1250),
and/or anti-GST (1:500), which were diluted in 10% goat
serum. After 90 min of incubation at room temperature
(RT) with primary antibodies, the samples were washed
five times with PBS and then incubated with secondary
antibodies for 90 min at RT. Antimouse-Cy3 (1:1500) and
antirabbit Alexa Flour 488 (1:1000), which were diluted in
10% goat serum, were used as secondary antibodies. After
washing with PBS five times, the samples were mounted
with ProLong Gold Antifade reagent containing DAPI
(Thermo Fischer Scientific, USA). Images were acquired
using a fluorescent microscope (Nikon, Japan).
2.10. Statistical analysis
Statistical significance values of the expression data were
determined by Student’s t-test. P < 0.001 was considered
significant.
3. Results
3.1. RIPK4 interacts with keratin 14
RIPK4, which encodes a 784-amino-acid protein with a
molecular weight of 87 kDa, has a conserved N-terminal
serine/threonine kinase domain, an intermediate domain,
and C-terminal ankyrin repeat domains (Figure 1A)
(Meylan, 2002). In this study, we applied a large-scale Y2H
screen in order to identify possible RIPK4-interacting
proteins. During the Y2H screen, a human keratinocyte
cDNA library was screened using the N-terminal RIPK4
kinase domain as bait. As a result of the screen, KRT14
was identified as a strong candidate that shows interaction even at highly stringent conditions (0.4 mM 3-AT)
(data not shown). Since the Y2H screen was performed
with the N-terminal region of RIPK4 and the cDNA clone
gathered from the screen was corresponding to the partial
ORF of KRT14, we analyzed whether full-length KRT14
and RIPK4 interact in mammalian cells as well. For this
purpose, HEK293T cells were transfected with full-length
Flag-tagged RIPK4 and GST-tagged KRT14 either alone
or together, and the interaction was determined by coimmunoprecipitation (Co-IP) assay. The data presented
in Figure 1B (lane 5) showed that the full-length RIPK4
and KRT14 specifically interact in mammalian cells as
well. In this particular experiment, we also analyzed the
RIPK4 domain(s) responsible for the KRT14 interaction
(Figures 1A and 1B). According to our results, the kinase
domain containing the N-terminal region of RIPK4 (Nter) specifically interacted with KRT14 (Figure 1B, lane
6). On the other hand, the intermediate domain of RIPK4
(ID) (Figure 1B, lane 7) and intermediate and ankyrin
domain-containing C-terminal region of RIPK4 (C-ter)
(Figure 1B, lane 8) showed no interaction with KRT14. In
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order to test whether the kinase activity of RIPK4 is required for KRT14 interaction, the Co-IP experiment was
repeated with kinase-dead K51R. According to our results, K51R continued to interact with KRT14 (Figure 1C,
lane 4). As indicated in Figure 1B (lanes 5 and 6), kinase
domain-intact full-length RIPK4 and N-terminal RIPK4
were detected as double bands, phosphorylated (P-RIPK4)
and unphosphorylated (RIPK4) forms, because of RIPK4’s
autophosphorylation activity (Bähr et al., 2000). In accordance, kinase-dead K51R appeared as a single band (Figure 1C, lane 4).
Since the detected interaction between RIPK4 and
KRT14 may be due to nonphysiological overexpression
levels, the interaction was also confirmed for endogenous
RIPK4 and KRT14 with Co-IP by using protein-specific
antibodies. The result of endogenous Co-IP indicated that
RIPK4 interacts with KRT14 in keratinocytes under physiological conditions as well (Figure 1D).
Next, we intended to explore whether the interaction
between RIPK4 and KRT14 is direct or part of a complex.
For this, GST-KRT14, which was produced in bacteria,
was immobilized to the beads and a GST pull-down assay
was performed by using His-RIPK4-expressing bacterial
lysate. GST alone was used to assess nonspecific binding
as a control. The results showed that RIPK4 interacts with
KRT14 directly (Figure 1E).
3.2. RIPK4 colocalizes with KRT14
In order to analyze the subcellular localization of RIPK4
and KRT14, an immunofluorescence assay was performed
in HeLa cells. In this assay, the cells expressing Flag-RIPK4
and GST-KRT14 either alone (Figure 2A) or together (Figure 2B) were fixed and analyzed. K51R was also included
in the experiment to analyze the effect of kinase activity
on the subcellular localization of RIPK4 and KRT14. As
shown in Figure 2A, when expressed alone, KRT14 showed
typical keratin filaments staining, which shows a cytoplasmic reticular pattern concentrating around the periphery
of the nucleus. On the other hand, RIPK4 appeared as
tiny dot-like structures diffused in the cytoplasm, mainly
around the nucleus. Different from RIPK4, K51R showed
coarse dot-like structures scattered through the cytoplasm
without surrounding the nucleus (Figure 2A). When
expressed together, RIPK4 showed colocalization with
KRT14, particularly at the ring-like structure around the
periphery of the nucleus (Figure 2B). On the other hand,
K51R did not colocalize with KRT14 (Figure 2B).
RIPK4 and KRT14 showed the same colocalization
pattern in keratinocyte HaCaT cells as well (Figure 2C).
3.3. RIPK4 does not interact with KRT5 and has no effect
on KRT5/KRT14 interaction
KRT14 and KRT5 form parallel coiled-coil heterodimers
to build a dynamic cytoskeleton in the basal layer of keratinocytes (Fuchs and Weber, 1994). As we showed the
interaction between RIPK4 and KRT14, we also analyzed
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Figure 1. Interaction of RIPK4 with KRT14. RIPK4 constructs, used in interaction assays, were schematized with domains (A).
HEK293T cells were transfected with indicated constructs. KRT14 was immunoprecipitated using anti-GST antibody followed by western blotting with anti-Flag and anti-GST antibodies (B, C). RIPK4 was immunoprecipitated using anti-RIPK4 in HaCaT cells. Rabbit
anti-Flag antibody was used as a control. The lysate was analyzed by western blotting using anti-KRT14 and anti-RIPK4 antibodies (D).
His-RIPK4 containing lysate was incubated with GST-KRT14 bounded beads and interaction was analyzed by western blotting using
anti-RIPK4 and anti-GST (E). Input indicates total lysate. α represents anti. * represents nonspecific band. ** represents heavy chains of
Flag (rabbit) and RIPK4 antibody, respectively.

whether RIPK4 interacts with KRT5 with Co-IP assay. In
this experiment, KRT5 was immunoprecipitated and the
presence of KRT14 and RIPK4 in the complex was analyzed. As expected, KRT5 interacted with KRT14; however,
there was no interaction between KRT5 and RIPK4 (Fig-

ure 3A, IP, panel 1, lanes 2 and 4). Then we analyzed the
effect of RIPK4 overexpression and depletion on KRT5/
KRT14 interaction by Co-IP assay (Figures 3B and 3C).
The RIPK4 overexpression, which was detected by antiRIPK4 in total lysates (Figure 3B, input, panel 2, lane 3),
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Figure 2. Colocalization of RIPK4 with KRT14. HeLa cells were transfected with Flag-RIPK4, Flag-K51R, or GSTKRT14 alone (A) or together (B). HaCaT cells were transfected with Flag-RIPK4 and GST-KRT14 together (C).
Cells were stained with anti-KRT14 (green) and anti-Flag (red) antibodies.

did not show any effect on KRT5 and KRT14 interaction

shown in Figure 3A, RIPK4 did not show any interaction

(Figure 3B, IP, panel 1, lanes 2 and 3). Similar to the result

with KRT5 (Figure 3B, IP, panel 3, lane 3).
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Figure 3. Effect of RIPK4 on KRT14/5 heterodimer formation. KRT5 was immunoprecipitated using anti-Flag
antibody followed by western blotting with anti-Flag and anti-GST antibodies (A). KRT5 was immunoprecipitated using anti-Flag antibody from the cell lysate of KRT14 alone and KRT14/RIPK4 together with overexpressed HEK293T cells. Western blot was performed with anti-Flag, anti-GST, and anti-RIPK4 antibodies (B).
KRT14 was immunoprecipitated from HaCaT and RIPK4 KO cell line using anti-KRT14 antibody (+). Mouse
anti-Flag antibody was used as a control (–). Western blot was performed with anti-KRT5, anti-KRT14, and antiRIPK4 antibodies (C). Input indicates total cell lysate. α represents anti. * represents nonspecific bands.

The CRISPR/Cas9 strategy was applied to deplete
RIPK4 expression in HaCaT cells. The mutant HaCaT
cell line (RIPK4 KO), in which RIPK4 expression is significantly suppressed (Supplementary Figure 1B), carries
heterozygous RIPK4 mutations. In one allele, one nucleotide insertion (66th base) resulted in a premature stop codon that led to knockout, while the other allele contained
an in-frame deletion of 12 nucleotides (between the 60th
and 73rd nucleotides) (data not shown). Even though the
12-nucleotide deletion encoded a protein, our immunob-

lot analysis showed that RIPK4 KO had approximately
20% of RIPK4 protein compared to the parental cell line,
which indicates that deletion destabilizes the protein (Supplementary Figure 1B).
Therefore, in order to analyze the effect of RIPK4 depletion on KRT5/14 interaction, endogenous KRT14 was
immunoprecipitated from the RIPK4 KO cell line by using
anti-KRT14 and its interaction with KRT5 was analyzed by
western blot using anti-KRT5. As shown, in total lysates,
RIPK4 expression was efficiently suppressed in RIPK4 KO
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cells (Figure 3C, input, panel 2, lane 2) and depletion of
RIPK4 did not affect the interaction between KRT5 and
KRT14 (Figure 3C, IP panel, lane 4).
4. Discussion
The epidermis provides an essential barrier against the
external environment and its continuity is maintained
with epidermal homeostasis, which is a delicate balance
between proliferation and differentiation of keratinocytes
(Fuchs and Nowak, 2008). RIPK4 is one of the key proteins
involved in keratinocyte differentiation (Holland et al.,
2002; Rountree et al., 2010). Consequently, its deficiency
in humans and mice leads to severe epidermal developmental defects (Holland et al., 2002; Kalay et al., 2012).
Despite its critical role in keratinocyte differentiation, little
is known about how RIPK4 performs its function in this
process. Identification of protein interacting partners gives
important clues about the functions of proteins (Phizicky
and Fields, 1995). As the Y2H system offers us an approach
for the identification of the interaction partners of proteins (Fields and Song, 1989), we applied the Y2H screen
and identified KRT14 as an interaction partner of RIPK4.
KRT14 is a member of intermediate filaments restricted
to basal-layer keratinocytes (Fuchs and Weber, 1994), and
similar to RIPK4, its expression is induced by the keratinocyte fate-determinant factor, p63 (Romano et al., 2007).
KRT14 is connected to desmosomes through interacting
with desmosomal structural protein PKP1 (Hofmann et
al., 2000). Interestingly, Pkp1 has been recently shown to
be involved in keratinocyte differentiation through its interaction and phosphorylation by RIPK4 (Lee et al., 2017).
All of this information points to the biological importance
of the RIPK4 and KRT14 interaction in keratinocyte differentiation. Therefore, in this study, the RIPK4/KRT14
interaction, which was identified by Y2H screen, was
confirmed in mammalian and bacterial cells (Figures 1B
and 1D) and was demonstrated to be direct (Figure 1E).
Ankyrin repeats, which are located at the C-terminus of
RIPK4, are well known for their roles in protein–protein
interactions (Sedgwick and Smerdon, 1999). However, the
interaction between RIPK4 and KRT14 was particularly
mediated by RIPK4’s N-terminal kinase domain (Figure
1B). Previously, RIPK4’s kinase activity was shown to be
dispensable for RIPK4 interaction with IRF6 (Huang et al.,
2018). Similar to this report, our result showed that RIPK4
kinase activity is not necessary for RIPK4/KRT14 interaction (Figure 1C).
Proteins localize to the same cellular compartments
to perform their functions (Loo et al., 2014). RIPK4 colocalized with KRT14, particularly around the periphery of
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the nucleus, which supported the notion that RIPK4 and
KRT14 interact to perform a cellular function. Kinasedead K51R, which shows a different cellular pattern from
the wild type, did not show any colocalization with KRT14
(Figure 2). This indicates that the disruption of kinase activity of RIPK4 does not affect its interaction with KRT14
but disrupts its cellular colocalization with KRT14.
KRT14 forms obligate heterodimers with KRT5 at
the basal layer of keratinocytes (Fuchs and Weber, 1994).
Therefore, we analyzed the effect of RIPK4 on KRT5/
KRT14 heterodimer formation and found that RIPK4 specifically interacts with basal keratins through KRT14 but
not with KRT5 (Figure 3A), and RIPK4 has no effect on
KRT5/KRT14 association (Figures 3B and 3C).
The main function of keratin filaments is to provide
structural support and to protect cells from mechanical
stress (Fuchs and Nowak, 2008). In addition to their welldocumented cytoprotective role, keratin filaments participate in various cellular processes such as migration, cell
growth, cell division, and differentiation (Kim et al., 2006;
Wöll et al., 2007; Busch et al., 2012; Loschke et al., 2015;
Sawant and Leube, 2017). These functions of keratin filaments are regulated by dynamic keratin turnover, which
is under the control of posttranslational modifications,
among which phosphorylation is the major determinant
(Snider and Omary, 2014; Kim et al., 2015; Loschke et al.,
2015). According to our results, RIPK4 does not show any
effect on building up keratin filaments through KRT5/
KRT14 heterodimerization; however, as a serine/threonine kinase RIPK4 may regulate keratin turnover through
interacting with and phosphorylating KRT14 and/or
KRT14-associated proteins. Supporting this idea, a quantitative phosphoproteomics analysis showed that KRT14
phosphorylation was downregulated in RIPK4-deficient
cells (Lee et al., 2017).
In conclusion, with this study we demonstrated that
RIPK4 interacts with the basal keratin network via KRT14.
The role of RIPK4/KRT14 interaction in keratinocyte
function merits further investigation, which will provide
important insight for the understanding of the molecular
basis of keratinocyte differentiation and associated skin
diseases.
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Supplementary Figure 1. (A, B) Analysis of RIPK4 expression in CRISPR/Cas9-applied HaCaT
cell line. CRISPR/Cas9 was applied to generate the RIPK4-depleted cell line. The schematic view of
selected gRNA sequence preceding PAM (red letter) and its location (between 50th and 68th nucleotides) on corresponding RIPK4 protein is indicated. RIPK4 domains – kinase domain (between
66th and 849th nucleotides, indicated with blue) and ankyrin domain (between 1311th and 2202nd
nucleotides, indicated with green) (A). CRISPR/Cas9-induced RIPK4 knockout clone (RIPK4 KO)
was analyzed in terms of protein expression by Western blot using anti-RIPK4 antibody (left side).
The band corresponding to RIPK4 protein was quantitated and normalized with β-actin (right side).
Error bars represent mean ± SD (n = 3). Statistical significance was determined by Student’s t-test
(*P < 0.001).
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